Captive reptile mortality rates in the home and implications for the wildlife trade

The trade in wildlife and keeping of exotic pets is subject to varying levels of national and international regulation and is a topic often attracting controversy. Reptiles are popular exotic pets and comprise a substantial component of the live animal trade. High mortality of traded animals raises welfare concerns, and also has implications for conservation if collection from the wild is required to meet demand. Mortality of reptiles can occur at any stage of the trade chain from collector to consumer. However, there is limited information on mortality rates of reptiles across trade chains, particularly amongst final consumers in the home. We investigated mortality rates of reptiles amongst consumers using a specialised technique for asking sensitive questions, additive Randomised Response Technique (aRRT), as well as direct questioning (DQ). Overall, 3.6% of snakes, chelonians and lizards died within one year of acquisition. Boas and pythons had the lowest reported mortality rates of 1.9% and chameleons had the highest at 28.2%. More than 97% of snakes, 87% of lizards and 69% of chelonians acquired by respondents over five years were reported to be captive bred and results suggest that mortality rates may be lowest for captive bred individuals. Estimates of mortality from aRRT and DQ did not differ significantly which is in line with our findings that respondents did not find questions about reptile mortality to be sensitive. This research suggests that captive reptile mortality in the home is rather low, and identifies those taxa where further effort could be made to reduce mortality rate

Notulae to the Italian alien vascular flora: 1

In this contribution, new data concerning the Italian distribution of alien vascular flora are presented. It includes new records, exclusions, and confirmations for Italy or for Italian administrative regions for taxa in the genera Agave, Arctotheca, Berberis, Bidens, Cardamine, Catalpa, Cordyline, Cotoneaster, Dichondra, Elaeagnus, Eragrostis, Impatiens, Iris, Koelreuteria, Lamiastrum, Lantana, Ligustrum, Limnophila, Lonicera, Lycianthes, Maclura, Mazus, Paspalum, Pelargonium, Phyllanthus, Pyracantha, Ruellia, Sorghum, Symphyotrichum, Triticum, Tulbaghia and Youngia

Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

Background: Albuminuria has been classically considered a marker of kidney damage progression in diabetic patients and it is routinely assessed to monitor kidney function. However, the role of a mild GFR reduction on the development of stage 653 CKD has been less explored in type 1 diabetes mellitus (T1DM) patients. Aim of the present study was to evaluate the prognostic role of kidney disease measures, namely albuminuria and reduced GFR, on the development of stage 653 CKD in a large cohort of patients affected by T1DM. Methods: A total of 4284 patients affected by T1DM followed-up at 76 diabetes centers participating to the Italian Association of Clinical Diabetologists (Associazione Medici Diabetologi, AMD) initiative constitutes the study population. Urinary albumin excretion (ACR) and estimated GFR (eGFR) were retrieved and analyzed. The incidence of stage 653 CKD (eGFR < 60 mL/min/1.73 m2) or eGFR reduction > 30% from baseline was evaluated. Results: The mean estimated GFR was 98 \ub1 17 mL/min/1.73m2 and the proportion of patients with albuminuria was 15.3% (n = 654) at baseline. About 8% (n = 337) of patients developed one of the two renal endpoints during the 4-year follow-up period. Age, albuminuria (micro or macro) and baseline eGFR < 90 ml/min/m2 were independent risk factors for stage 653 CKD and renal function worsening. When compared to patients with eGFR > 90 ml/min/1.73m2 and normoalbuminuria, those with albuminuria at baseline had a 1.69 greater risk of reaching stage 3 CKD, while patients with mild eGFR reduction (i.e. eGFR between 90 and 60 mL/min/1.73 m2) show a 3.81 greater risk that rose to 8.24 for those patients with albuminuria and mild eGFR reduction at baseline. Conclusions: Albuminuria and eGFR reduction represent independent risk factors for incident stage 653 CKD in T1DM patients. The simultaneous occurrence of reduced eGFR and albuminuria have a synergistic effect on renal function worsening

Future effects of ozone on carbon sequestration and climate change policy using a global biogeochemical model

Author Posting. © The Authors, 2004. This is the author's version of the work. It is posted here by permission of Springer for personal use, not for redistribution. The definitive version was published in Climatic Change 73 (2005): 345-373, doi:10.1007/s10584-005-6776-4.Exposure of plants to ozone inhibits photosynthesis and therefore reduces vegetation production and carbon sequestration. The reduced carbon storage would then require further reductions in fossil fuel emissions to meet a given CO2 concentration target, thereby increasing the cost of meeting the target. Simulations with the Terrestrial Ecosystem Model (TEM) for the historical period (1860-1995) show the largest damages occur in the Southeast and Midwestern regions of the United States, eastern Europe, and eastern China. The largest reductions in carbon storage for the period 1950-1995, 41%, occur in eastern Europe. Scenarios for the 21st century developed with the MIT Integrated Global Systems Model (IGSM) lead to even greater negative effects on carbon storage in the future. In some regions, current land carbon sinks become carbon sources, and this change leads to carbon sequestration decreases of up to 0.4 Pg C yr-1 due to damage in some regional ozone hot spots. With a climate policy, failing to consider the effects of ozone damage on carbon sequestration would raise the global costs over the next century of stabilizing atmospheric concentrations of CO2 equivalents at 550 ppm by 6 to 21%. Because stabilization at 550 ppm will reduce emission of other gases that cause ozone, these additional benefits are estimated to be between 5 and 25% of the cost of the climate policy. Tropospheric ozone effects on terrestrial ecosystems thus produce a surprisingly large feedback in estimating climate policy costs that, heretofore, has not been included in cost estimates.This study was funded by the Biocomplexity Program of the U.S. National Science Foundation (ATM-0120468), the Methods and Models for Integrated Assessment Program of the U.S. National Science Foundation (DEB-9711626) and the Earth Observing System Program of the U.S. National Aeronautics and Space Administration (NAG5-10135). The IGSM has been developed as part of the Joint Program on the Science and Policy of Global Change with the support of a government-industry partnership including in addition to the above the US Department of Energy (901214-HAR; DE-FG02-94ER61937; DE-FG0293ER61713), the US Environmental Protection Agency (X-827703-01-0; XA-83042801-0), the National Aeronautics and Atmospheric Administration (NA16GP2290) and a group of corporate sponsors from the United States, Japan, United Kingdom, Germany, France, and Norway

Reliability of electrophysiologic anal tests in predicting the outcome of sacral nerve modulation for fecal incontinence

INTRODUCTION: Sacral nerve modulation has been demonstrated to be a new efficacious treatment for fecal incontinence. The effectiveness of the procedure is preliminarily tested by means of a peripheral nerve evaluation. Integrity of the sacral neural pathway is generally believed to be a necessary condition for a good response, but no data are available to confirm whether electrophysiologic anal tests are predictive of the clinical outcome of the peripheral nerve evaluation. METHODS: Eighty-two incontinent patients underwent the peripheral nerve evaluation after full evaluation of the anorectal physiology. Univariate analysis was performed, and the positive predictive value, sensitivity, and specificity were calculated for each of the tests. RESULTS: Forty-six patients had successful results to the peripheral nerve evaluation and were subjected to permanent implant of a sacral electrostimulator. Anal sphincter electromyography had been performed in 60 patients, whereas pudendal nerve terminal motor latency had been assessed in 68 and evoked sacral potentials in 29 patients. Anal electromyography was statistically related to the outcome of the peripheral nerve evaluation (P = 0.0004) with a positive predictive value of 81 percent, a sensitivity of 44 percent, and a specificity of 81 percent. Pudendal nerve terminal motor latency on the right side did not correlate with the outcome, but left pudendal nerve terminal motor latency was weakly correlated (P = 0.02), although both tests had a low positive predicting value and sensitivity vs. good specificity. Evoked sacral potentials did not correlate with the outcome and had a low positive predictive value, sensitivity, and specificity. CONCLUSIONS: Simple anal sphincter electromyography can predict the outcome of the peripheral nerve evaluation with good positive predictive value and specificity in patients with fecal incontinence. Other, more expensive, electrophysiologic anal tests do not add further prognostic information

Neuromodulation for fecal incontinence: Outcome in 16 patients with definitive implant: The Initial Italian Sacral Neurostimulation Group (GINS) experience

Purpose: Sacral nerve modulation appears to offer a valid treatment option for some patients with fecal incontinence and functional defects of the internal anal sphincter or of the striated muscle. Methods: Sixteen patients with fecal incontinence (4 males; mean age, 51.4 (range, 27-79) years) with intact or surgically repaired (n = 1) anal sphincter underwent permanent sacral nerve stimulation implant. Cause was traumatic in two patients, and associated disorders included scleroderma (2 patients) and spastic paraparesis (1 patient); eight (50 percent) of the patients also had urinary incontinence, and two (12.5 percent) had nonobstructive urinary retention. All patients were selected on the basis of positive findings from at least one peripheral nerve evaluation. The stimulating electrode was positioned in the S2 (1 patient), S3 (14 patients), or S4 (1 patient) sacral foramen. Results: Mean follow-up was 15.5 (range, 3-45) months. Mean preimplant Williams score decreased from 4.1 \ub1 0.9 (range, 2-5) to 1.25 \ub1 0.5 (range, 1-2) (P = 0.01, Wilcoxon test), and the number of incontinence accidents for liquid or solid stool in 14 days decreased from 11.5 \ub1 4.8 (range, 2-20) before implant to 0.6 \ub1 0.9 (range, 0-2) at the last follow-up. Important manometric data were an increase in mean maximal pressure at rest of 37.7 \ub1 14.9 mmHg (implantable pulse generator 49.1 \ub1 18.7, P = 0.04) and in mean maximal pressure during squeeze (prestimulation 67.3 \ub1 21.1 mmHg, implantable pulse generator 82.6 \ub1 21.0, P = 0.09). Conclusions: Neuromodulation can be considered an option for fecal incontinence. However, an accurate clinical and instrumental evaluation and careful patient selection are required to optimize outcome